News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
284 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (335)
2 (389)
3 (283)
4 (319)
5 (131)
6 (6)
7 (4)
8 (279)
9 (329)
10 (321)
11 (307)
12 (125)
13 (3)
14 (8)
15 (254)
16 (287)
17 (204)
18 (246)
19 (94)
20 (14)
21 (3)
22 (244)
23 (272)
24 (225)
25 (255)
26 (87)
27 (4)
28 (5)
29 (233)
30 (284)
31 (251)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
BioNTech-Pfizer Increase COVID-19 Vaccine Output Target Again
With the ongoing global pandemic, BioNTech and Pfizer announced that they will be boosting their manufacturing capacity of the COVID-19 vaccine to 2.5 billion for 2021.
March 30, 2021
·
2 min read
·
Kristiane Polido
Drug Development
AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks
AbbVie won the NDA on the strength of definitive results in a Phase III ADVANCE trial, where atogepant met all six secondary endpoints at the 30-60 mg dose range, proving statistically significant in heading off migraines in nearly 2500 adult participants who experience them between 4-14 days per month.
March 30, 2021
·
2 min read
·
Heather McKenzie
Drug Development
Global Vaccine Passports Edge Closer, Speeding Arrival of the Next “Normal”
Vaccine passports are an interim step that can speed the return of some semblance of normality by allowing the rapidly growing numbers of vaccinated people to travel more easily and to attend typically crowded sporting events, concerts and religious services.
March 30, 2021
·
5 min read
·
Gail Dutton
Business
After About 50 Years, the mRNA Revolution is Here
Between the Moderna and Pfizer-BioNTech COVID-19 vaccines, there are two mRNA therapeutics on the market … the only two.
March 30, 2021
·
4 min read
·
Mark Terry
Drug Development
Bionic Sight’s Optogenetic Therapy Yields Bright Results
The first four patients that were administered BS01, Bionic Sight’s investigational gene therapy for advanced retinitis pigmentosa (RP), all reported the ability to detect light and motion. Two of the patients were also able to detect direction.
March 30, 2021
·
2 min read
·
Kristiane Polido
Policy
PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy
PTC Therapeutics, Inc. announced that the European Commission has granted marketing authorization to Evrysdi™ for the treatment of spinal muscular atrophy in patients 2 months and older.
March 30, 2021
·
9 min read
Deals
Breakthrough year in the development of Selvita - strategic acquisition & strong financial results
In 2020, Selvita recorded EUR 31.8 million in revenues, achieving an increase of 35% on a year on year (y/y) basis. Commercial revenues increased in 2020 to EUR 25.5 million, showing a 39% y/y increase
March 30, 2021
·
6 min read
Policy
Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome
Health Canada acknowledges that the preclinical safety data are robust and sufficient to file a Clinical Trial Application aimed at treating hospitalized COVID-19 patients at risk of developing ARDS
March 30, 2021
·
7 min read
Drug Development
InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis
InDex Pharmaceuticals Holding AB announced that the company has entered an agreement for services with global clinical research organization Parexel Biotech for the phase III study CONCLUDE.
March 30, 2021
·
4 min read
Critical Limb Ischemia Treatment Market: Increase in Preference for Revascularization as Treatment Option to Drive Devices Segment
The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.
March 30, 2021
·
4 min read
Previous
2 of 29
Next